# Vornado Realty Trust: financial statements, quarterly

VNO · NYSE · CIK 899689 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vno.md) · [Financials](/companies/vno/financials.md) · [Filings](/companies/vno/filings.md) · [Insiders](/companies/vno/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vno/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [451](/filings/0000899689-24-000039.md) | [442 d](/filings/0000899689-26-000009.md) | [436](/filings/0000899689-25-000019.md) | [450](/filings/0000899689-25-000032.md) | [443](/filings/0000899689-25-000040.md) | [458 d](/filings/0000899689-26-000009.md) | [462](/filings/0000899689-26-000026.md) | [441](/filings/0000899689-26-000046.md) | [454](/filings/0000899689-25-000040.md) | [454 d](/filings/0000899689-26-000009.md) | [459](/filings/0000899689-26-000026.md) | [462](/filings/0000899689-26-000046.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [87.9](/filings/0000899689-26-000046.md) | not reported | not reported | not reported | [89.6](/filings/0000899689-26-000046.md) |
| Income tax | $m | [11.7](/filings/0000899689-24-000039.md) | [8.4 d](/filings/0000899689-26-000009.md) | [6.7](/filings/0000899689-25-000019.md) | [5.3](/filings/0000899689-25-000032.md) | [4.9](/filings/0000899689-25-000040.md) | [5.8 d](/filings/0000899689-26-000009.md) | [7.2](/filings/0000899689-26-000026.md) | [4.1](/filings/0000899689-26-000046.md) | [(5.6)](/filings/0000899689-25-000040.md) | [7.8 d](/filings/0000899689-26-000009.md) | [5.9](/filings/0000899689-26-000026.md) | [3.6](/filings/0000899689-26-000046.md) |
| Net income | $m | [68.4](/filings/0000899689-24-000039.md) | [(45.5) d](/filings/0000899689-26-000009.md) | [6.5](/filings/0000899689-25-000019.md) | [50.8](/filings/0000899689-25-000032.md) | [(3.6)](/filings/0000899689-25-000040.md) | [16.7 d](/filings/0000899689-26-000009.md) | [102](/filings/0000899689-26-000026.md) | [759](/filings/0000899689-26-000046.md) | [27.1](/filings/0000899689-25-000040.md) | [16.1 d](/filings/0000899689-26-000009.md) | [(7.3)](/filings/0000899689-26-000026.md) | [32.0](/filings/0000899689-26-000046.md) |
| Diluted EPS | $ per share | [0.28](/filings/0000899689-24-000039.md) | not reported | [(0.05)](/filings/0000899689-25-000019.md) | [0.18](/filings/0000899689-25-000032.md) | [(0.10)](/filings/0000899689-25-000040.md) | not reported | [0.43](/filings/0000899689-26-000026.md) | [3.70](/filings/0000899689-26-000046.md) | [0.06](/filings/0000899689-25-000040.md) | not reported | [(0.12)](/filings/0000899689-26-000026.md) | [0.08](/filings/0000899689-26-000046.md) |
| Basic EPS | $ per share | [0.28](/filings/0000899689-24-000039.md) | not reported | [(0.05)](/filings/0000899689-25-000019.md) | [0.19](/filings/0000899689-25-000032.md) | [(0.10)](/filings/0000899689-25-000040.md) | not reported | [0.45](/filings/0000899689-26-000026.md) | [3.87](/filings/0000899689-26-000046.md) | [0.06](/filings/0000899689-25-000040.md) | not reported | [(0.12)](/filings/0000899689-26-000026.md) | [0.09](/filings/0000899689-26-000046.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.0](/filings/0000899689-24-000039.md) | [1.0](/filings/0000899689-26-000009.md) | [0.9](/filings/0000899689-25-000019.md) | [0.9](/filings/0000899689-25-000032.md) | [0.8](/filings/0000899689-25-000040.md) | [0.7](/filings/0000899689-26-000046.md) | [0.6](/filings/0000899689-26-000026.md) | [1.2](/filings/0000899689-26-000046.md) | [1.0](/filings/0000899689-25-000040.md) | [0.8](/filings/0000899689-26-000046.md) | [1.1](/filings/0000899689-26-000026.md) | [0.7](/filings/0000899689-26-000046.md) |
| Total assets | $bn | [16.5](/filings/0000899689-23-000059.md) | [16.2](/filings/0000899689-25-000004.md) | [16.2](/filings/0000899689-24-000021.md) | [16.2](/filings/0000899689-24-000033.md) | [16.1](/filings/0000899689-24-000039.md) | [16.0](/filings/0000899689-26-000009.md) | [15.6](/filings/0000899689-25-000019.md) | [15.6](/filings/0000899689-25-000032.md) | [15.7](/filings/0000899689-25-000040.md) | [15.5](/filings/0000899689-26-000046.md) | [15.9](/filings/0000899689-26-000026.md) | [15.6](/filings/0000899689-26-000046.md) |
| Total liabilities | $bn | [9.9](/filings/0000899689-23-000059.md) | [9.8](/filings/0000899689-25-000004.md) | [9.8](/filings/0000899689-24-000021.md) | [9.8](/filings/0000899689-24-000033.md) | [9.8](/filings/0000899689-24-000039.md) | [9.8](/filings/0000899689-26-000009.md) | [9.4](/filings/0000899689-25-000019.md) | [8.6](/filings/0000899689-25-000032.md) | [8.7](/filings/0000899689-25-000040.md) | [8.7](/filings/0000899689-26-000046.md) | [9.2](/filings/0000899689-26-000026.md) | [8.9](/filings/0000899689-26-000046.md) |
| Long-term debt | $bn | [2.6](/filings/0000899689-23-000059.md) | [2.6](/filings/0000899689-25-000004.md) | [2.6](/filings/0000899689-24-000021.md) | [2.6](/filings/0000899689-24-000033.md) | [2.6](/filings/0000899689-24-000039.md) | [2.6](/filings/0000899689-26-000009.md) | [2.1](/filings/0000899689-25-000019.md) | [2.1](/filings/0000899689-25-000032.md) | [2.3](/filings/0000899689-25-000040.md) | [2.3](/filings/0000899689-26-000046.md) | [2.8](/filings/0000899689-26-000026.md) | [2.6](/filings/0000899689-26-000046.md) |
| Shareholders' equity | $bn | [5.8](/filings/0000899689-23-000059.md) | [5.5](/filings/0000899689-25-000004.md) | [5.5](/filings/0000899689-24-000021.md) | [5.6](/filings/0000899689-24-000033.md) | [5.3](/filings/0000899689-24-000039.md) | [5.2](/filings/0000899689-26-000009.md) | [5.3](/filings/0000899689-25-000019.md) | [6.1](/filings/0000899689-25-000032.md) | [6.1](/filings/0000899689-25-000040.md) | [6.0](/filings/0000899689-26-000046.md) | [6.0](/filings/0000899689-26-000026.md) | [5.8](/filings/0000899689-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.1 d](/filings/0000899689-24-000039.md) | [211 d](/filings/0000899689-26-000009.md) | [31.5](/filings/0000899689-25-000019.md) | [195 d](/filings/0000899689-25-000032.md) | [105 d](/filings/0000899689-25-000040.md) | [206 d](/filings/0000899689-26-000009.md) | [52.0](/filings/0000899689-26-000026.md) | [1,027 d](/filings/0000899689-26-000046.md) | [33.2 d](/filings/0000899689-25-000040.md) | [146 d](/filings/0000899689-26-000009.md) | [47.7](/filings/0000899689-26-000026.md) | [164 d](/filings/0000899689-26-000046.md) |
| Dividends paid | $m | [0.0 d](/filings/0000899689-24-000039.md) | [57.1 d](/filings/0000899689-26-000009.md) | [0.0](/filings/0000899689-24-000021.md) | [0.0 d](/filings/0000899689-24-000033.md) | [0.0 d](/filings/0000899689-24-000039.md) | [141 d](/filings/0000899689-26-000009.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [5.9 d](/filings/0000899689-24-000039.md) | [0.0 d](/filings/0000899689-26-000009.md) | not reported | not reported | [0.0 d](/filings/0000899689-24-000039.md) | [0.0 d](/filings/0000899689-26-000009.md) | [0.0](/filings/0000899689-26-000026.md) | [0.0 d](/filings/0000899689-26-000046.md) | not reported | not reported | [79.9](/filings/0000899689-26-000026.md) | [53.5 d](/filings/0000899689-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [192](/filings/0000899689-23-000059.md) | [192](/filings/0000899689-24-000021.md) | [195](/filings/0000899689-24-000033.md) | [193](/filings/0000899689-24-000039.md) | [190](/filings/0000899689-25-000019.md) | [194](/filings/0000899689-25-000032.md) | [191](/filings/0000899689-25-000040.md) | [201](/filings/0000899689-26-000026.md) | [201](/filings/0000899689-26-000046.md) | [200](/filings/0000899689-25-000040.md) | [190](/filings/0000899689-26-000026.md) | [194](/filings/0000899689-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 186,720,531 at 2026-06-30, from the cover of the [10-Q filed 2026-08-03](/filings/0000899689-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.